Acción INLB ITEM 9 LABS CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Item 9 Labs Corp.

Acciones

INLB

US46564C2035

Diferido OTC Markets
Otros sitios de cotización
 15:30:01 07/05/2024 		Varia. Cinco días. Varia. 1 de enero.
0,0001 USD 0,00 % Gráfico intradía de Item 9 Labs Corp. -50,00 % -94,74 %
2023 Artículo 9 Labs Corp. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de junio de 2023 CI
2023 Douglas Bowden dimite como Presidente del Consejo de Administración de Item 9 Labs Corp, con efecto a partir del 18 de julio de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Item 9 Labs Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
Item 9 Labs : Bankruptcy - Form 8-K
Douglas Bowden Resigned as Chairman of the Board of Directors of Item 9 Labs Corp, Effective July 18, 2023
Douglas Bowden Resign as Interim CEO of Item 9 Labs Corp
Item 9 Labs Corp. Announces Resignation of Shane Evans as A Member of the Board of Directors
Item 9 Labs Corp. cancelled the acquisition of Sessions Cannabis from Steven Fry, Najla Guthrie, Darryl Allen, Louis Laskovski, 2628146 Ontario Ltd. and 11949896 Canada Inc.
Item 9 Labs Corp. Executes Major Restructuring to Pave the Way to Profitability
Item 9 Labs Corp. Announces Management Changes
Item 9 Labs Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
ITEM 9 LABS CORP. - 8-K - LABS CORP. : Change in Directors or Principal Officers, Other Events (form 8-K)
Item 9 Labs Corp. Announces Resignation of Michael Weinberger as Member of the Board of Directors
Item 9 Labs Corp. Announces CEO Changes
Item 9 Labs Corp. Announces the Resignation of Lawrence X. Taylor as Board of Director
Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls
Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls
ITEM 9 LABS CORP. - 8-K - LABS CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)
Notice to the Annual General Meeting of MilDef Group AB (publ)
Unity Rd. To Exhibit at 2023 Multi-Unit Franchising Conference
Item 9 Labs Corp. To Present at the Benzinga Spring Cannabis Capital Conference
Item 9 Labs : Accelaration/Increase of Financial Obligation - Form 8-K
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción INLB
  4. Noticias Item 9 Labs Corp.
  5. Otros idiomas